Neuland Laboratories has reported results for third quarter ended December 31, 2013.
The company has reported more than two fold jump in its net profit at Rs 6.82 crore for the quarter, as compared to Rs 3.27 crore for the same quarter in the previous year. Total income from operations of the company increased by 22.49% at Rs 131.55 crore for quarter under review as compared to Rs 107.40 crore for the quarter ended December 31, 2012.
Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.
The company has reported more than two fold jump in its net profit at Rs 6.82 crore for the quarter, as compared to Rs 3.27 crore for the same quarter in the previous year. Total income from operations of the company increased by 22.49% at Rs 131.55 crore for quarter under review as compared to Rs 107.40 crore for the quarter ended December 31, 2012.
Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.
No comments:
Post a Comment